Edition:
United States

Xencor Inc (XNCR.OQ)

XNCR.OQ on NASDAQ Stock Exchange Global Market

42.89USD
21 Sep 2018
Change (% chg)

$-2.50 (-5.51%)
Prev Close
$45.39
Open
$45.24
Day's High
$45.82
Day's Low
$42.70
Volume
487,008
Avg. Vol
121,629
52-wk High
$48.31
52-wk Low
$19.00

Chart for

About

Xencor, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. It has developed two clinical-stage product candidates, using its Immune Inhibitor Fc platform: XmAb5871, which is in two Phase II trials... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $2,394.38
Shares Outstanding(Mil.): 55.83
Dividend: --
Yield (%): --

Financials

  XNCR.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -1.16 -- --
ROI: -14.21 1.54 12.72
ROE: -14.36 0.30 14.84

BRIEF-Xencor Reports Q1 Loss Per Share $0.62

* Q1 EARNINGS PER SHARE VIEW $-0.46 -- THOMSON REUTERS I/B/E/S

May 07 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $44.06 +0.31
Novartis AG (NOVN.S) CHF81.88 -0.06
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
AstraZeneca plc (AZN.L) 5,670.00 +98.00
GlaxoSmithKline plc (GSK.L) 1,531.40 +45.60
AbbVie Inc (ABBV.N) $92.26 -0.42
Bristol-Myers Squibb Co (BMY.N) $62.25 +0.50
Bristol-Myers Squibb Co (BMYMP.PK) $1,034.45 --
Amgen, Inc. (AMGN.OQ) $205.10 0.00

Earnings vs. Estimates